1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.
Peng Zhan, Xinyong Liu, Zengjun Fang, Christophe Pannecouque, Erik De Clercq
Index: Bioorg. Med. Chem. 17(17) , 6374-9, (2009)
Full Text: HTML
Abstract
The development of new HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) offers the possibility of generating novel structures of increased potency. Based on the bioisosteric principle, novel series of 1,2,3-selenadiazole thioacetanilide derivatives were designed, and synthesized using an original synthetic route, structurally confirmed by spectral analysis, and evaluated for their anti-HIV activity in MT-4 cells. The results showed that only compound 7f possessed potent activity against HIV-1 replication (EC(50)=2.45 microM) similar to the prototype series of sulfanyltriazoles. None of the compounds were active against HIV-2 replication.
Related Compounds
Related Articles:
The metabolism of thioacetanilide in the rat.
1983-08-01
[Xenobiotica 13(8) , 475-82, (1983)]
2009-08-15
[Bioorg. Med. Chem. 17(16) , 5775-81, (2009)]
2010-12-01
[Bioorg. Med. Chem. 20(18) , 5527-36, (2012)]
[Substantiation of maximum permissible levels of thioacylanilide in the air of work areas].
1986-07-01
[Gig. Tr. Prof. Zabol. (7) , 51-2, (1986)]
2008-03-07
[J. Org. Chem. 73(5) , 1852-63, (2008)]